Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ki H. Kim is active.

Publication


Featured researches published by Ki H. Kim.


Archives of Biochemistry and Biophysics | 1982

The use of crystallography, graphics, and quantitative structure-activity relationships in the analysis of the papain hydrolysis of X-phenyl hippurates

R. Nelson Smith; Corwin Hansch; Ki H. Kim; Bruce Omiya; Glen Fukumura; Cynthia Dias Selassie; P. Y. C. Jow; Jeffrey M. Blaney; Robert Langridge

Abstract The effect of 3- and 4-monosubstitution and 3,5-disubstitution on the phenyl leaving group of the papain-catalyzed hydrolysis of 27 phenyl hippurates is reported. The Michaelis-Menten constant ( K m ) at 25.0 °C and pH 6.0 was determined for the substrates and, in addition, the first-order rate constant ( k ) for the uncatalyzed hydrolysis under the same conditions was measured. A quantitative structure-activity relationship was derived from the K m values. The conclusions from this analysis are in excellent agreement with the binding mode of the hippurates as shown by a molecular graphics analysis of the binding cavity which has been defined by X-ray crystallography.


Bioorganic & Medicinal Chemistry Letters | 2000

Antifungal rapamycin analogues with reduced immunosuppressive activity

Daniel A. Dickman; H. Ding; Qun Li; Angela M. Nilius; Darlene Balli; Stephen J. Ballaron; James M. Trevillyan; Morey L. Smith; Louis Seif; Ki H. Kim; Aparna V. Sarthy; Robert C. Goldman; Jacob J. Plattner; Youssef L. Bennani

Several 1,2,3,4-tetrahydro- and 7-N-hydroxycarbamate derivatives of the natural product rapamycin were prepared and assayed for their immunosuppressive and antifungal profiles. Substitutions at the 7-position indicate the possibility of a differentiated immunosuppressive to antifungal profile, whereas 40-position variants of the tetrahydro-analogues did not show similar differentiated activity.


Journal of Medicinal Chemistry | 2002

Design, Synthesis, and Structure−Activity Relationship of 6-Alkynylpyrimidines as Potent Adenosine Kinase Inhibitors

Arthur Gomtsyan; Chih-Hung Lee; Mark A. Matulenko; Ki H. Kim; Elizabeth A. Kowaluk; Carol T. Wismer; Joe Mikusa; Haixia Yu; Kathy L. Kohlhaas; Michael F. Jarvis; Shripad S. Bhagwat


Journal of Medicinal Chemistry | 1993

Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis.

Asim K. Debnath; Corwin Hansch; Ki H. Kim; Yvonne C. Martin


Journal of Organic Chemistry | 1991

DIRECT PREDICTION OF LINEAR FREE ENERGY SUBSTITUENT EFFECTS FROM 3D STRUCTURES USING COMPARATIVE MOLECULAR FIELD ANALYSIS. I, ELECTRONIC EFFECTS OF SU BSTITUTED BENZOIC ACIDS

Ki H. Kim; Yvonne C. Martin


Journal of Medicinal Chemistry | 2006

Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 : A structural basis for the reduction of albumin binding

George S. Sheppard; Jieyi Wang; Megumi Kawai; Steve D. Fidanze; Nwe Y. BaMaung; Scott A. Erickson; David M. Barnes; Jason S. Tedrow; Lawrence Kolaczkowski; Anil Vasudevan; David Park; Gary T. Wang; William J. Sanders; Robert A. Mantei; Fabio Palazzo; Lora Tucker-Garcia; Pingping Lou; Qian Zhang; Chang H. Park; Ki H. Kim; Andrew M. Petros; Edward T. Olejniczak; David G. Nettesheim; Phillip Hajduk; Jack Henkin; Richard R. Lesniewski; Steven K. Davidsen; Randy L. Bell


Archive | 2003

Sulfonamides having antiangiogenic and anticancer activity

Kenneth M. Comess; Scott A. Erickson; Jack Henkin; Douglas M. Kalvin; Megumi Kawai; Ki H. Kim; Nwe Y. BaMaung; Chang Hoon Park; George S. Sheppard; Anil Vasudevan; Jieyi Wang; David M. Barnes; Steve D. Fidanze; Lawrence Kolaczkowski; Robert A. Mantei; David Park; William J. Sanders; Jason S. Tedrow; Gary T. Wang


Journal of Medicinal Chemistry | 1991

Direct prediction of dissociation constants (pKa's) of clonidine-like imidazolines, 2-substituted imidazoles, and 1-methyl-2-substituted-imidazoles from 3D structures using a comparative molecular field analysis (CoMFA) approach.

Ki H. Kim; Yvonne C. Martin


Journal of Medicinal Chemistry | 1990

Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships.

James B. Summers; Ki H. Kim; Hormoz Mazdiyasni; James H. Holms; James D. Ratajczyk; Andrew O. Stewart; Richard D. Dyer; George W. Carter


Journal of Medicinal Chemistry | 2001

Discovery of 4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine, an Orally Active, Non-Nucleoside Adenosine Kinase Inhibitor

Chih-Hung Lee; Meiqun Jiang; Marlon Cowart; Greg Gfesser; Richard Perner; Ki H. Kim; Yu Gui Gu; Michael T. Williams; Michael F. Jarvis; Elizabeth A. Kowaluk; and Andrew O. Stewart; Shripad S. Bhagwat

Collaboration


Dive into the Ki H. Kim's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jack Henkin

Northwestern University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Megumi Kawai

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge